Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, May 23, 2024 | Back issues
Courthouse News Service Courthouse News Service

Pain Killers

WASHINGTON (CN) - The Drug Enforcement Agency plans to take a preemptive strike against illegal distribution of a new painkiller, tapentadol, by listing it in Schedule II alongside the popularly abused substances morphine, oxycodone (Percodan) and hydromorphone (Dilaudid).

The Food and Drug Administration approved tapentadol's safety in November, but its maker, Johnson & Johnson, has to wait to market it until the DEA determines which set of restrictions to put on its movement. Schedule II generally allows for a controlled use of prescriptions, with distribution being carefully monitored by the DEA.

The DEA will accept written public comments on the matter until March 19.

Click the document icon on the front page for details and links to the regulations. The document icon under the "Sockeye, Bluefin, Lead & More" heading leads to other new regulations.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...